An α2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the β-Blocker Bucindolol in chronic heart failure
Michael R. Bristow, Guinevere A. Murphy, Heidi Krause-Steinrauf, Jeffrey L. Anderson, John F. Carlquist, Surai Thaneemit-Chen, Vaishali Krishnan, William T. Abraham, Brian D. Lowes, J. David Port, Gordon W. Davis, Laura C. Lazzeroni, Alastair D. Robertson, Phillip W. Lavori, Stephen B. Liggett
Fingerprint
Dive into the research topics of 'An α<sub>2C</sub>-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the β-Blocker Bucindolol in chronic heart failure'. Together they form a unique fingerprint.